- Global Pharma News & Resources

Respiratory Pathogen Testing Kits Market will Witness a Substantial CAGR of 6.5% | Latest Trends, COVID-19 Impact and Future Trends By 2030 | Abbott Laboratories, Thermo Fisher Scientific & so on…

Respiratory pathogen testing kits sales are expected to see a staggering growth due to mandatory workplace testing, particularly in high-risk occupations along with growth in funding for respiratory diagnostics. The global respiratory pathogen testing kits market is anticipated to record a CAGR of over 5% in 2020.

Though the molecular diagnostic procedure has come out as a significant part of the research in the life science sector, high expenses involved in operating molecular process (particularly by private laboratories) can constrain market growth, especially in the developing economies

Key Developments & Product Innovation 

Antigen testing, rapid molecular assays, immunofluorescence assays, RT-PCR, and vital culture are the diagnostic tests accessible to detect viral and bacterial infections in the current circumstances. “PathoDetect Covid-19 Qualitative PCR kit” manufactured by India-based Mylab, operates on the theory of RT-PCR. The kit is anticipated to detect infection in 2.5 hours (in contrast to 7.5 hours taken earlier). This aspect is likely to catalyze the respiratory pathogen test kits demand in India and the other nations of APAC; as more infections can be detected in less time (seeing the growing number of cases and density of population in this region).

For more insights into the Market, Request a Sample of this Report@

In wake of Covid-19, the Australian government declared a USD 1.68 billion package comprehensive of respiratory clinics’ network (a new Medicare item to help tele-consultations and communications campaign) in March 2020. The Covid-19 pandemic directed the Russian Direct Investment Fund (RDIF) to produce 500,000 test kits with its partners in March 2020. The manufacturing has augmented to 2.5 million kits per week afterward.

COVID-19 Impact Analysis

COVID-19 outbreak is adversely affecting the overall mental health of individuals, resorting them to unhealthy habits. This could impact the respiratory tract and boost the demand for more testing kits. As such, the market would foresee sizable expansion with the addition of post-COVID-19 modifications apart from the present respiratory deformities.

Respiratory Pathogen Testing Kits: Regional Insights

Europe and the U.S. keep on to be the most lucrative respiratory pathogen testing kits markets worldwide. They jointly hold about 55% of the market share and are projected to keep on with the same trait in the assessment period. Besides Covid-19 and the other subsisting fungal infections /bacterial/viral; a sedentary lifestyle in both these regions is fueling the market.

For any Queries Linked with the Report, Ask an Analyst@

The APAC market is additionally picking up; with several local participants engaging in the production of respiratory pathogen testing kits to supply to the rising cases of Covid-19. Moreover, growing economies in the APAC market have been due to gastrointestinal tract infections since low-income groups have a propensity to pay less consideration to dietary hygiene. Another booster for the market is air pollution. According to IQAir, over 20 of the most polluted nations in the world belong to the APAC region. The uncontrollable inhalation of sulfur dioxide and carbon monoxide induces choking of the respiratory tract; thus causing a rise in respiratory pathogen testing kits demand.

Competitive Landscape

A few companies operating in the global market are –


  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Becton, Dickinson, and Company
  • Danaher Corporation


  • bioMérieux Inc.
  • Hoffmann-La Roche Ltd.

Asia Pacific

  • MyLab
  • Altona Diagnostics

Explore FMI’s Coverage of the Healthcare Industry

Centrifugal Blood Pump Market: Get insights on the outbound Centrifugal Blood Pump Market through FMI’s report covering detailed quantitative and qualitative analysis for projection period 2020-2030.

Pharmaceutical Intermediates Market: FMI’s exhaustive study on the Pharmaceutical Intermediates Market covers the latest trends, innovations, key players, and popular strategies for the period 2020-2030.

Respiratory Inhaler Devices Market: Obtain detailed analysis on the Respiratory Inhaler Devices Market through FMI’s report covering competitive analysis, key regions, and segmental analysis for 2020-2030.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.


Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries:
For Media Enquiries:

Editor Details

Last Updated: 12-Feb-2021